Oligonucleotides: A Cornerstone for Therapeutics & More
ISPE
OCTOBER 27, 2022
Oligonucleotides are a cornerstone of a burgeoning class of drugs classified as nucleic acid therapeutics. Since 2016, drug approvals per clinical campaign have outpaced the average across all modalities, resulting in 11 FDA-approved therapies in that span. Figure 1 shows a typical block flow sequence of unit operations. 1 Moumné, L.,
Let's personalize your content